NCT06824831View on ClinicalTrials.gov

Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

September 2, 2024

Conditions
MastectomyLymphadenectomyBreast Neoplasm Malignant FemaleBreast SurgerySeroma Following Procedure
Interventions
DRUG

Patients receive microporous polysaccharide hemospheres.

Patients were randomized to receive microporous polysaccharide hemospheres, after mastectomy was done.

DRUG

Patients DO NOT receive microporous polysaccharide hemospheres.

Patients were randomized to NOT receive microporous polysaccharide hemispheres after mastectomy was done.

Trial Locations (1)

46010

Hospital Clínico Universitario, Valencia

All Listed Sponsors
lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT06824831 - Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy | Biotech Hunter | Biotech Hunter